Tagmentation-based Indexing for Methylation Sequencing as a novel method of high-throughput methylation clock measurement
Tagmentation-based Indexing for Methylation Sequencing as a novel method of high-throughput methylation clock measurement
批准号:
10273233
负责人:
DAVID A. SINCLAIR
金额:
$62.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-17 至 2023-08-31
关键词:
AddressAgeAgingAnimalsBar CodesBiologicalBiological AgingBiological AssayBiological MarkersBiologyBiotinCell physiologyCellsCost MeasuresDNADNA MethylationDNA Transposable ElementsDNA methylation profilingDevelopmentDiseaseEffectivenessEmbryonic DevelopmentEpigenetic ProcessFeasibility StudiesGeneticGoalsHealthHealthcareHumanIn VitroIndividualInterventionIntervention StudiesLibrariesLightLongevityMalignant NeoplasmsMammalsMeasurementMeasuresMediatingMedical OncologyMedical ResearchMedicineMethodsMethylationModificationMonitorMusPharmacologyPreparationProcessProtocols documentationRNARepressionReproducibilityResearchRoleSamplingSignal TransductionSiteSpeedTechnologyTicksTissuesVariantX Inactivationanimal tissueanti agingbasebisulfitebisulfite sequencingcancer diagnosiscarcinogenesiscell typecombinatorialcostcost effectivedesignepigenetic markerepigenomicsexperimental studygenetic associationhealthspanhigh throughput screeninghuman tissueimprintindexinginsightmortalitynovelpersonalized medicinesingle cell analysissingle cell sequencingtooltumor
中文摘要
项目摘要
尽管表观遗传时钟在表观基因组学研究和人类健康中的重要性,
甲基化年龄的测量在很大程度上仍然是昂贵的,并且不适于高通量测定。我们
正在开发一种新的方法,称为基于标记的甲基化测序索引(TIME-seq),
表观遗传时钟位点的成本有效的高通量甲基化测序。TIME-seq将通过以下方式降低成本
在单个步骤(标签片段化)中连接条形码和片段化DNA,并通过使用
生物素化RNA诱饵。可行性研究表明,TIME-seq与多路复用兼容,
成功地丰富了时钟站点。我们的第一个目标是优化TIME-seq作为一种高通量检测,
测量基于DNA甲基化的生物标志物。我们将通过优化生物素-RNA的设计来实现这一目标
诱饵,以适应不同的DNA甲基化时钟从人类和小鼠。我们还将比较
因此,TIME-seq的重现性和准确性与表观遗传时钟分析的已建立测定法的重现性和准确性相比是非常重要的。我们预测
TIME-seq将允许甲基化测序实验的规模增加至少两个数量级
并通过降低每个样本的成本使时钟测量更容易实现。而且还要
修改TIME-seq以用于单细胞。目前,DNA甲基化时钟测量的是
组织中许多细胞的年龄,尽管组织中只有少量细胞类型
贡献了大部分信号。因此,我们将开发单细胞TIME-seq(scTIME-seq)方案
基于组合索引来理解细胞水平上的表观遗传衰老。该方法将允许
测量甲基化时钟位点的细胞间变异,并将深入了解
衰老最终,我们的目标是增加对靶向甲基化测序的访问,并设想它成为一种
用于研究和个性化医疗的标准工具。
英文摘要
PROJECT SUMMARY
Despite the importance of the epigenetic clock in epigenomics research and to human health, methods to
measure methylation age remain for the most part expensive and not amenable to high throughput assays. We
are developing a new method, called Tagmentation-based Indexing for MEthylation sequencing (TIME-seq), for
cost-effective high throughput methylation sequencing of epigenetic clock sites. TIME-seq will reduce costs by
attaching barcodes and fragmenting DNA in a single step (tagmentation) and by enriching for clock sites using
biotinylated RNA baits. Feasibility studies demonstrate that TIME-seq is compatible with multiplexing and
successfully enriches for clock sites. Our first goal is to optimize TIME-seq as a high-throughput assay for
measuring DNA methylation-based biomarkers. We will accomplish this by optimizing the design of biotin-RNA
baits to accommodate diverse DNA methylation clocks from humans and mice. We will also compare the
reproducibility and accuracy of TIME-seq to those of established assays for epigenetic clock analysis. We predict
that TIME-seq will allow for an increase in the scale of methylation sequencing experiments by at least two orders
of magnitude and make clock measurement more accessible by lowering the cost per sample. Moreover, we will
adapt TIME-seq for use on single cells. Currently, DNA methylation clocks measure the average methylation
age of many cells in a tissue, despite the possibility that only a small number of cell types within a tissue
contribute to the majority of the signal. Therefore, we will develop a single-cell TIME-seq (scTIME-seq) protocol
based on combinatorial indexing to understand epigenetic aging at the cellular level. This method will allow for
measurement of cell-to-cell variation at methylation clock sites and will provide insight into the mechanisms of
aging. Ultimately, we aim to increase access to targeted methylation sequencing, and envision it becoming a
standard tool used in research and personalized medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using cellular co-biosis and age programmable mice to derive a global interaction map of aging hallmarks
-
批准号:10721454
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2023
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Nicotinamide Mononucleotide (NMN) as a Novel Therapeutic in the Treatment of Oral Mucositis
-
批准号:9770831
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2018
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Uncovering the Human Secretome
-
批准号:9344966
-
项目类别:
-
资助金额:$118.65万
-
财政年份:2017
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Uncovering the Human Secretome
-
批准号:10223179
-
项目类别:
-
资助金额:$118.65万
-
财政年份:2017
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Uncovering the Human Secretome
-
批准号:9751141
-
项目类别:
-
资助金额:$118.65万
-
财政年份:2017
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Elucidating mechanisms of SIRT1 activation
-
批准号:9315825
-
项目类别:
-
资助金额:$50.83万
-
财政年份:2016
-
负责人:DAVID A. SINCLAIR
-
依托单位:
2009 Biology of Aging Gordon Research Conference
-
批准号:7613586
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2008
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:7383794
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:8048190
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:7589667
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:7260016
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:9268167
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:10116232
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:9884526
-
项目类别:
-
资助金额:$40.01万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:9101926
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:7797997
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:8387561
-
项目类别:
-
资助金额:$43.24万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:8723013
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:8534005
-
项目类别:
-
资助金额:$39.8万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
THE BIOLOGY AND UTILITY SIRT1- MEDIATED NEUROPROTECTION
-
批准号:7085094
-
项目类别:
-
资助金额:$31.12万
-
财政年份:2006
-
负责人:DAVID A. SINCLAIR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: